Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Oramed Pharmaceuticals Inc. shareholders
As of Sep 30, 2026, 89 institutions reported holding Oramed Pharmaceuticals Inc., 42.3% of its shares. Largest: Mercer Global Advisors Inc, Aquamarine Financial (Cayman) Ltd and Murchinson Ltd. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Oramed Pharmaceuticals Inc. | Change | Filed |
|---|---|---|---|---|
| Mercer Global Advisors Inc | 3.81M | 8.8% | +2,142 | Nov 16, 2026 |
| Aquamarine Financial (Cayman) Ltd | 2.65M | 6.1% | +141K | Nov 13, 2026 |
| Murchinson Ltd. | 2.14M | 4.9% | +852K | Nov 13, 2026 |
| Gem Investment Advisors, LLC | 2M | 4.6% | no change | Nov 13, 2026 |
| BlackRock | 1.84M | 4.2% | +232K | Nov 13, 2026 |
| BML Capital Management, LLC | 884K | 2.0% | +18,123 | Nov 6, 2026 |
| Boothbay Fund Management, LLC | 821K | 1.9% | +242K | Nov 16, 2026 |
| Geode Capital | 501K | 1.2% | +227 | Nov 6, 2026 |
| State Street | 467K | 1.1% | +225K | Nov 12, 2026 |
| Renaissance Technologies | 294K | 0.68% | +110K | Nov 12, 2026 |